Tracking molecular malfunctions in metastatic colorectal cancer to find new avenues for treatment

Researchers from Hokkaido University and the University of South Florida Health have discovered a key mechanism that allows metastatic colorectal cancer to evade the immune system, challenging a 30-year-old theory about cancer. This breakthrough could lead to more effective immunotherapies and personalized treatment strategies for patients with advanced colorectal cancer. Understanding how cancer cells hide from immune detection opens new possibilities for combination therapies. The findings represent significant progress in developing targeted approaches to improve outcomes for patients with mCRC, one of the most challenging forms of cancer to treat.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: October 10, 2026 at 10:01 AM



